Refine
Has Fulltext
- yes (6)
Is part of the Bibliography
- yes (6)
Document Type
- Journal article (6)
Language
- English (6)
Keywords
- Bordetella pertussis (2)
- SARS-CoV-2 (2)
- acetylsalicylic acid (1)
- adenylate cyclase toxin (1)
- airway epithelia (1)
- anthocyanin (1)
- antiviral activity (1)
- aspirin (1)
- astaxanthin (1)
- bilberry (1)
Institute
- Lehrstuhl für Tissue Engineering und Regenerative Medizin (6)
- Institut für Virologie und Immunbiologie (3)
- Theodor-Boveri-Institut für Biowissenschaften (2)
- Institut für Organische Chemie (1)
- Julius-von-Sachs-Institut für Biowissenschaften (1)
- Klinik und Poliklinik für Hals-, Nasen- und Ohrenkrankheiten, plastische und ästhetische Operationen (1)
EU-Project number / Contract (GA) number
- 607051 (1)
Acetylsalicylic acid and salicylic acid inhibit SARS-CoV-2 replication in precision-cut lung slices
(2022)
Aspirin, with its active compound acetylsalicylic acid (ASA), shows antiviral activity against rhino- and influenza viruses at high concentrations. We sought to investigate whether ASA and its metabolite salicylic acid (SA) inhibit SARS-CoV-2 since it might use similar pathways to influenza viruses. The compound-treated cells were infected with SARS-CoV-2. Viral replication was analysed by RTqPCR. The compounds suppressed SARS-CoV-2 replication in cell culture cells and a patient-near replication system using human precision-cut lung slices by two orders of magnitude. While the compounds did not interfere with viral entry, it led to lower viral RNA expression after 24 h, indicating that post-entry pathways were inhibited by the compounds.